A major obstacle to malaria elimination is the great capacity of the parasite and vector
populations to evolve in response to malaria control interventions. The widespread use of …

Background Schistosomiasis is a disease that significantly impacts human health in the
developing world. Effective diagnostics are urgently needed for improved control of this disease. …

The Plasmodium falciparum serine repeat antigen (SERA) is one of the blood stage malaria
vaccine candidates. The malaria genome project has revealed that SERA is a member of …

Pre-existing and intervening low-density Plasmodium infections complicate the conduct of
malaria clinical trials. These infections confound infection detection endpoints, and their …

Antibodies to the C terminus of the Plasmodium falciparum merozoite surface protein,
PfMSP-1 19 , may inhibit merozoite invasion or block the effects of inhibitory antibodies. Here, …

Background Up to now a malaria vaccine remains elusive. The Plasmodium falciparum
serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage …

An infection with Plasmodium falciparum may lead to severe malaria as a result of excessive
binding of infected erythrocytes in the microvasculature. Vascular adhesion is mediated by …

Severe human malaria is attributable to an excessive sequestration of Plasmodium falciparum
–infected and uninfected erythrocytes in vital organs. Strains of P. falciparum that form …

We describe the MalariaGEN Pf7 data resource, the seventh release of Plasmodium falciparum
genome variation data from the MalariaGEN network. It comprises over 20,000 samples …

The extent to which duplications and deletions occur in the Plasmodium falciparum genome,
outside of the subtelomeres, and their contribution to the virulence of the malaria parasite is …